RE:FloridaThe way I see it, it comes down to growth strategy and risk. CURA is by far the most aggressive in its expansion in market reach. Boris's strategy is to prepare for growth and pave the path for future growth. He has done that, but at a cost, he had to dilute and borrow (normal for an aggressive growth strategy), but the debt is now significant and the US continues to delay and faulter with reform, stifling profit in the US and putting pressure on CURA. TRUL and GTII have a more focused and conservative approach and have remained in the US until the reform happens, so they both have less debt, however, they will have more work to do in expansion internationally. Alot comes down to if you think a company should go it alone and build its empire (CURA) or if you think it is better to merge and or aquire when the market is more stable at home (TRUL, GTII) You also have to consider if you think a big whale will come into the sector, and if so, will they want a US focused or international focused company. Still many moving parts in all of these MJ players.